PAVAN REDDY to Receptors, Tumor Necrosis Factor, Type I
This is a "connection" page, showing publications PAVAN REDDY has written about Receptors, Tumor Necrosis Factor, Type I.
Connection Strength
0.213
-
TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes. Biol Blood Marrow Transplant. 2012 Oct; 18(10):1525-32.
Score: 0.093
-
A biomarker panel for acute graft-versus-host disease. Blood. 2009 Jan 08; 113(2):273-8.
Score: 0.073
-
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI Insight. 2017 02 09; 2(3):e89798.
Score: 0.033
-
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease. Biol Blood Marrow Transplant. 2005 Sep; 11(9):680-7.
Score: 0.015